Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability
- Supplementary File 1:
ZIP-Document (ZIP, 205 KiB)
Goulet, D.R.; Chatterjee, S.; Lee, W.-P.; Waight, A.B.; Zhu, Y.; Mak, A.N.-S. Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability. Antibodies 2022, 11, 6. https://doi.org/10.3390/antib11010006
Goulet DR, Chatterjee S, Lee W-P, Waight AB, Zhu Y, Mak AN-S. Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability. Antibodies. 2022; 11(1):6. https://doi.org/10.3390/antib11010006
Chicago/Turabian StyleGoulet, Dennis R., Soumili Chatterjee, Wai-Ping Lee, Andrew B. Waight, Yi Zhu, and Amanda N.-S. Mak. 2022. "Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability" Antibodies 11, no. 1: 6. https://doi.org/10.3390/antib11010006